Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Oct - Newspaper publication regarding opening of special window for transfer and dematerialization of physical shares
Source: Bse
Chemicals stocks · Large cap · NSE
Supreme Petrochem Limited manufactures polystyrene and other styrenic products. It operates an ABS plant and is expanding its EPS capacity. The company focuses on both OEM and non-OEM segments, maintaining a debt-free balance sheet and funding capex through internal accruals.
SMA20 +7.0% / mo · MACD − · sector -4.2pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Today's candle is provisional from the latest intraday quote; completed-candle scans remain unchanged.
Adjusted completed-session prices, rebased to 100
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +22.3% · PAT +190.2% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +22% YoY · PAT +190% YoY · margin expansion · +7% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,715 Cr | +22.3% | +6.8% |
| EBITDA | ₹332 Cr | +186.2% | +30.2% |
| Operating margin | 19.0% | +1100 bps | +300 bps |
| PAT | ₹238 Cr | +190.2% | +40.8% |
| PAT margin | 13.9% | +803 bps | +336 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 38. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 47 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Chemicals — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4 FY26 revenue grew 3% YoY to INR 1,587 crores, driven by higher volumes and better spreads. Operating EBITDA surged 75% YoY to INR 253 crores, with margins improving to 15.9%. FY26 revenue declined 11% YoY due to lower styrene monomer prices, but volumes grew 2%.
Q4 FY26 showed strong operational performance with significant EBITDA growth and margin expansion, driven by higher volumes and better spreads. Full-year revenue was impacted by lower raw material prices, but volume growth was maintained. Capacity expansions and new product ramp-ups are key for future growth, though raw material volatility and non-OEM demand softness pose near-term challenges.
Maas ABS plant restarted with modified arrangements, operating at 65% capacity. Product has been well accepted in the market.
Successfully commissioned on April 14, 2026, enhancing EPS capacity from 85,000 TPA to 115,000 TPA at Amdoshi complex.
Expects 50-60% more volume this year, targeting 65-70% utilization. Onboarded two AC manufacturers in Sri City.
Value-added grades for refrigerators and ACs provide better profitability, with the company present across various user segments.
Successfully commissioned on April 14, 2026, enhancing EPS capacity from 85,000 TPA to 115,000 TPA at Amdoshi complex.
Original capacity 70,000 TPA, currently operating at 65% of design capacity (effectively 45,000 TPA) due to impacted equipment.
Company plans around INR 250 crores for FY27, mainly for infrastructure and other related activities, not PS/EPS projects at Panipat yet.
Demand from OEM segments remained healthy during Q4 FY26.
Demand growth for EPS came from packing, construction, and cold storage segments last year.
Company was able to meet domestic demand through sufficient inventory, material in transit, and sourcing from alternate geographies.
Styrene monomer prices increased sharply in March 2026 due to West Asia conflict and supply disruption through Strait of Hormuz.
Non-OEM segments witnessed some softness in Q4 and demand has taken a big beating in April due to high prices, labor, and gas shortages.
West Asia conflict impacted Middle East shipments, increasing shipping time and freight rates, making exports challenging.
Management is aware that inventory loss might come the moment the situation normalizes and prices drop.
West Asia conflict directly impacts raw material supply, costs, and global shipping, creating a very dynamic and fluid situation.
Company is not entering into new contracts with OEMs due to the fluid situation in raw material pricing and freight costs.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Q4 results are compared YoY to assess performance against a typically strong seasonal quarter. Full-year results are also compared YoY to understand the overall trend despite raw material price fluctuations.
Increased to 100,664 tons in Q4 FY26, reflecting a growth of about 5.4% compared to 95,556 tons in Q4 FY25.
Stood at 363,203 metric tons, reflecting a growth of about 2% compared to 355,967 metric tons in FY25.
Remained healthy at over 80% for the year.
Improved to 15.9% from 9.4% in Q4 FY25.
Expects 8-10% volume growth in FY27 if normalcy returns by June end (Q2 onwards), subject to global situation.
Still aiming for FY28 commissioning for the second ABS line, irrespective of current Phase-I equipment issues.
PS and EPS projects at Panipat are delayed, pending more clarity on IOC's styrene monomer plant commissioning date.
Company remains debt-free with an investable surplus of INR 700 crores as of March 2026, funding all capex through internal accruals.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Styrene Monomer (SM) Prices | Around $1,500/ton, after peaking at $1,650/ton in March. | Stabilization and moderation of SM prices, and easing of supply chain disruptions from West Asia. |
| Maas ABS Plant Utilization | 65% of design capacity (effectively 45,000 TPA) due to impacted equipment. | Restoration of the impacted equipment and ramp-up to 100% of original capacity (70,000 TPA). |
| Non-OEM Demand Recovery | Subdued in April due to high prices, labor unavailability, and gas shortages. | Signs of recovery in non-OEM demand as raw material prices stabilize and other market conditions improve. |
| FY27 Volume Growth | Management expects 8-10% growth if normalcy returns by Q2 FY27. | Actual volume growth achievement, especially given Q1 headwinds and ABS plant operational status. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 81st percentile of the scored universe and 70th percentile within Chemicals. Main check: results consistency is weak at 55/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Chemicals: 70th pctile, median 73 · Large: 62nd pctile, median 73
74 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse